HK$6.17
0.16% today
Hong Kong, Oct 16, 10:09 am CET
ISIN
BMG0171K1018
Symbol
0241
Index

Alibaba Health Information Technology Target price 2025 - Analyst rating & recommendation

Alibaba Health Information Technology Classifications & Recommendation:

Buy
59%
Hold
32%
Sell
9%

Alibaba Health Information Technology Price Target

Target Price HK$5.61
Price HK$6.17
Deviation
Number of Estimates 19
19 Analysts have issued a price target Alibaba Health Information Technology 2026 . The average Alibaba Health Information Technology target price is HK$5.61. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 22 analysts: 13 Analysts recommend Alibaba Health Information Technology to buy, 7 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Alibaba Health Information Technology stock has an average upside potential 2026 of . Most analysts recommend the Alibaba Health Information Technology stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Mar '25 2026
Estimates
Revenue Billion HK$ 33.38 37.61
13.22% 12.67%
EBITDA Margin 5.41% 6.56%
87.65% 21.29%
Net Margin 4.68% 7.06%
43.21% 50.81%

20 Analysts have issued a sales forecast Alibaba Health Information Technology 2026 . The average Alibaba Health Information Technology sales estimate is

HK$37.6b
Unlock
. This is
12.67% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
HK$42.3b 26.66%
Unlock
, the lowest is
HK$35.0b 4.95%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 HK$33.4b 13.22%
2026
HK$37.6b 12.67%
Unlock
2027
HK$41.7b 11.00%
Unlock
2028
HK$45.6b 9.33%
Unlock
2029
HK$56.5b 23.81%
Unlock
2030
HK$63.4b 12.19%
Unlock
2031
HK$69.8b 10.07%
Unlock
2032
HK$76.6b 9.83%
Unlock

15 Analysts have issued an Alibaba Health Information Technology EBITDA forecast 2026. The average Alibaba Health Information Technology EBITDA estimate is

HK$2.5b
Unlock
. This is
61.40% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
HK$3.4b 120.31%
Unlock
, the lowest is
HK$1.8b 20.03%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 HK$1.8b 112.45%
2026
HK$2.5b 36.74%
Unlock
2027
HK$3.1b 27.31%
Unlock
2028
HK$3.9b 23.36%
Unlock
2029
HK$5.2b 34.02%
Unlock
2030
HK$5.2b 0.78%
Unlock
2031
HK$5.8b 12.23%
Unlock
2032
HK$6.4b 11.41%
Unlock

EBITDA Margin

2025 5.41% 87.65%
2026
6.56% 21.29%
Unlock
2027
7.53% 14.79%
Unlock
2028
8.49% 12.75%
Unlock
2029
9.20% 8.36%
Unlock
2030
8.13% 11.63%
Unlock
2031
8.29% 1.97%
Unlock
2032
8.41% 1.45%
Unlock

20 Alibaba Health Information Technology Analysts have issued a net profit forecast 2026. The average Alibaba Health Information Technology net profit estimate is

HK$2.7b
Unlock
. This is
70.03% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
HK$3.5b 123.90%
Unlock
, the lowest is
HK$1.8b 15.49%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 HK$1.6b 62.14%
2026
HK$2.7b 70.03%
Unlock
2027
HK$3.2b 20.78%
Unlock
2028
HK$4.0b 23.25%
Unlock
2029
HK$5.4b 36.95%
Unlock
2030
HK$6.2b 14.22%
Unlock
2031
HK$7.1b 14.29%
Unlock
2032
HK$8.1b 15.01%
Unlock

Net Margin

2025 4.68% 43.21%
2026
7.06% 50.81%
Unlock
2027
7.69% 8.92%
Unlock
2028
8.67% 12.74%
Unlock
2029
9.59% 10.61%
Unlock
2030
9.76% 1.77%
Unlock
2031
10.13% 3.79%
Unlock
2032
10.61% 4.74%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Mar '25 2026
Estimates
Earnings Per Share HK$ 0.10 0.17
42.86% 70.00%
P/E 37.39
EV/Sales 2.32

20 Analysts have issued a Alibaba Health Information Technology forecast for earnings per share. The average Alibaba Health Information Technology EPS is

HK$0.17
Unlock
. This is
70.00% higher
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
HK$0.22 120.00%
Unlock
, the lowest is
HK$0.11 10.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 HK$0.10 42.86%
2026
HK$0.17 70.00%
Unlock
2027
HK$0.20 17.65%
Unlock
2028
HK$0.25 25.00%
Unlock
2029
HK$0.34 36.00%
Unlock
2030
HK$0.38 11.76%
Unlock
2031
HK$0.44 15.79%
Unlock
2032
HK$0.51 15.91%
Unlock

P/E ratio

Current 61.80 12.88%
2026
37.39 39.50%
Unlock
2027
30.96 17.20%
Unlock
2028
25.12 18.86%
Unlock
2029
18.34 26.99%
Unlock
2030
16.06 12.43%
Unlock
2031
14.05 12.52%
Unlock
2032
12.22 13.02%
Unlock

Based on analysts' sales estimates for 2026, the Alibaba Health Information Technology stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.61 29.85%
2026
2.32 11.25%
Unlock
2027
2.09 9.91%
Unlock
2028
1.91 8.54%
Unlock
2029
1.54 19.23%
Unlock
2030
1.37 10.87%
Unlock
2031
1.25 9.16%
Unlock
2032
1.14 8.95%
Unlock

P/S ratio

Current 2.87 26.03%
2026
2.55 11.24%
Unlock
2027
2.30 9.91%
Unlock
2028
2.10 8.54%
Unlock
2029
1.70 19.23%
Unlock
2030
1.51 10.87%
Unlock
2031
1.37 9.15%
Unlock
2032
1.25 8.95%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today